Conventional Lipid Profile and Lipoprotein(a) Concentrations in Treated Patients with Rheumatoid Arthritis

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Rheumatology

• Publication date

  2009-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3899/jrheum.080928PMID 19369465
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lipid profiles in patients with rheumatoid arthritis: mechanisms and the impact of treatment.

  2009cited by this paper
• Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study

  2009cited by this paper
• Native, oxidized lipoprotein(a) and lipoprotein(a) immune complex in patients with active and inactive rheumatoid arthritis: plasma concentrations and relationship to inflammation.

  2008cited by this paper
• High HDL‐cholesterol in women with rheumatoid arthritis on low‐dose glucocorticoid therapy

  2008cited by this paper
• Role of lipoprotein(a) in cardiovascular disease current and future perspectives.

  2008cited by this paper
• Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study.

  2008cited by this paper
• HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis.

  2007cited by this paper
• Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis.

  2006cited by this paper
• Modest but sustained increase of serum high density lipoprotein cholesterol levels in patients with inflammatory arthritides treated with infliximab.

  2006cited by this paper
• Indications for lowering LDL cholesterol in rheumatoid arthritis: an unrecognized problem.

  2006cited by this paper
• Cardiovascular death in rheumatoid arthritis: a population-based study.

  2005cited by this paper
• Rheumatoid arthritis: a disease associated with accelerated atherogenesis.

  2005cited by this paper
• Lp(a) lipoprotein and lipids in patients with rheumatoid arthritis: serum levels and relationship to inflammation

  2005cited by this paper
• Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study.

  2005cited by this paper
• Lipid profiles among US elderly with untreated rheumatoid arthritis--the Third National Health and Nutrition Examination Survey.

  2005cited by this paper
• Dyslipoproteinemia in patients with active rheumatoid arthritis: effects of disease activity, sex, and menopausal status on lipid profiles.

  2004cited by this paper
• Cardiovascular Morbidity and Mortality in Women Diagnosed With Rheumatoid Arthritis

  2003cited by this paper
• Programa de Prevención Secundaria de la Arteriosclerosis de un hospital universitario. Resultados y factores predictivos del curso clínico

  2003cited by this paper
• Lipoprotein(a) and the atherothrombotic process: Mechanistic insights and clinical implications

  2003cited by this paper
• [Secondary Preventive Program of atherosclerosis in a university hospital. Results and predictors of clinical course].

  2003cited by this paper
• Cardiovascular risk factors in Chilean patients with rheumatoid arthritis.

  2002cited by this paper
• Effects of antirheumatic therapy on serum lipid levels in patients with rheumatoid arthritis: a prospective study.

  2002cited by this paper
• Corticosteroid therapy increases HDL-cholesterol concentrations in patients with active sarcoidosis and hypoalphalipoproteinemia.

  2002cited by this paper
• The prevalence of rheumatoid arthritis in the general population of Spain.

  2002cited by this paper
• Elevated levels of small, low-density lipoprotein with high affinity for arterial matrix components in patients with rheumatoid arthritis: possible contribution of phospholipase A2 to this atherogenic profile.

  2001cited by this paper
• High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors.

  2001cited by this paper
• Infection and inflammation-induced proatherogenic changes of lipoproteins.

  2000cited by this paper
• Triglyceride, small, dense low-density lipoprotein, and the atherogenic lipoprotein phenotype

  2000cited by this paper
• Dieta y riesgo cardiovascular en Espana (DRECE II). Descripcion de la evolucion del perfil cardiovascular

  2000cited by this paper
• Perfil lipídico de la población española, estudio DRECE (Dieta y Riesgo de Enfermedad Cardiovascular en España)

  1999cited by this paper
• [Lipid profile of the Spanish population: the DRECE (diet and risk of cardiovascular disease in Spain) study. DRECE study group].

  1999cited by this paper
• Serum lipoprotein(a) and apolipoprotein(a) phenotypes in patients with rheumatoid arthritis.

  1999cited by this paper
• Lipid profiles in untreated patients with rheumatoid arthritis.

  1999cited by this paper
• Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.

  1995cited by this paper
• Interleukin-6 causes hypocholesterolemia in middle-aged and old rhesus monkeys.

  1995cited by this paper
• Glucocorticoid therapy decreases serum lipoprotein(a) concentration in rheumatic diseases.

  1993cited by this paper
• The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

  1988cited by this paper
• Measurement of patient outcome in arthritis.

  1980cited by this paper
• Prediction of creatinine clearance from serum creatinine.

  1975cited by this paper
• Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

  1972cited by this paper

• Mendelian randomization analysis does not support a causal influence between lipoprotein(A) and immune-mediated inflammatory diseases

  2025cites this paper
• Lipoprotein(a) at the crossroads of inflammation and atherosclerosis in rheumatoid arthritis: A narrative review.

  2025cites this paper
• Targeting the vivid facets of apolipoproteins as a cardiovascular risk factor in rheumatoid arthritis.

  2024cites this paper
• Lipoproteins Levels in Rheumatoid Arthritis

  2023cites this paper
• Dyslipidemia in rheumatoid arthritis: the possible mechanisms

  2023cites this paper
• Circulating CTRP5 in rheumatoid arthritis: an exploratory biomarker study

  2022cites this paper
• Prevalence of metabolic syndrome in patients with rheumatoid arthritis in eastern China—A hospital based study

  2021cites this paper
• Lipid Metabolism Profiles in Rheumatic Diseases

  2021cites this paper
• Divergence of Cardiovascular Biomarkers of Lipids and Subclinical Myocardial Injury Among Rheumatoid Arthritis Patients With Increased Inflammation

  2020cites this paper
• Untying the correlation between apolipoproteins and rheumatoid arthritis

  2020cites this paper
• Untying the correlation between apolipoproteins and rheumatoid arthritis

  2020cites this paper
• Hyperlipoprotein(a) in patients with spondyloarthritis: results of the Cardiovascular in Rheumatology (CARMA) project.

  2019cites this paper
• Correlation between lipid profile and lipoprotein (a) with inflammatory activity of rheumatoid arthritis

  2019cites this paper
• Cardiovascular Safety of Biologics and JAK Inhibitors in Patients with Rheumatoid Arthritis

  2018cites this paper
• NMR-Based Serum Metabolomics Revealed Distinctive Metabolic Patterns in Reactive Arthritis Compared with Rheumatoid Arthritis.

  2018cites this paper
• Alterations and diagnosis potential of serum lipid profiles in rheumatoid arthritis patients

  2017cites this paper
• LC-MS-based lipidomic analysis of serum samples from patients with rheumatoid arthritis

  2017cites this paper
• Lipoprotein(a) concentrations in rheumatoid arthritis on biologic therapy: Results from the CARdiovascular in rheuMAtology study project.

  2017cites this paper
• Assessment of intracranial vessels in association with carotid atherosclerosis and brain vascular lesions in rheumatoid arthritis

  2017cites this paper
• The role of methotrexate and low‐dose prednisolone on adiponectine levels and insulin resistance in patients with rheumatoid arthritis naïve to disease‐modifying antirheumatic drugs

  2016cites this paper
• Association of Lp ( a ) with CRP in patients of Rheumatoid Arthritis

  2016cites this paper
• Prothrombotic biomarkers in patients with rheumatoid arthritis: the beneficial effect of IL-6 receptor blockade.

  2016cites this paper
• EFFECT OF DISEASE-MODIFYING ANTIRHEUMATIC DRUGS ON THE VALUES OF APOLIPOPROTEIN A-1 AND ACUTE PHASE REACTANTS IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS.

  2016influential citation
• The Juvenile Idiopathic Arthritis Patients Run a Higher Risk for Dyslipidemia as Compared to Adults with Arthritis

  2014cites this paper
• Inflammation, lipid metabolism and cardiovascular risk in rheumatoid arthritis: A qualitative relationship?

  2014cites this paper
• THE INFLUENCE OF ADDING ANTIBIOTIC IN TREATMENT OF RHEUMATOID ARTHRITIS PATIENTS ON STREPTOCOCCUS PYOGENES CARRIER RATE AND ON THE LIPIDS PROFILE

  2014cites this paper
• Treating dyslipidemias: is inflammation the missing link?

  2014cites this paper
• Serum levels of lipoprotein(a) and E-selectin are reduced in rheumatoid arthritis patients treated with methotrexate or methotrexate in combination with TNF-α-inhibitor.

  2013cites this paper
• Pro-atherogenic lipid changes and decreased hepatic LDL receptor expression by tocilizumab in rheumatoid arthritis.

  2013cites this paper
• Evaluation of dyslipidaemia in patients with rheumatoid arthritis in South Indian population

  2013cites this paper
• Serum lipid profile in psoriatic patients: correlation between vascular adhesion protein 1 and lipoprotein (a)

  2013cites this paper
• Dyslipidemia and Xanthine Oxidoreductase Level in Jordanian Patients with Rheumatoid Arthritis

  2013cites this paper
• The Prevalence of Dyslipidemia and Xanthine Oxidoreductase level in Jordanian Patients with Rheumatoid Arthritis

  2013cites this paper
• Addressing cardiovascular risk factors and therapy effects in rheumatoid arthritis: implications for atherosclerosis and cardiovascular disease

  2012cites this paper
• Consenso 2012 da Sociedade Brasileira de Reumatologia sobre o manejo de comorbidades em pacientes com artrite reumatoide

  2012cites this paper
• Rheumatoid arthritis: why to treat only arthritis, knowing that comorbidities are common and determine morbidity and mortality?

  2012cites this paper
• Atherosclerosis in Rheumatic Diseases

  2012cites this paper
• 2012 Brazilian Society of Rheumatology Consensus on the management of comorbidities in patients with rheumatoid arthritis.

  2012cites this paper
• Dyslipidaemia in Rheumatological Autoimmune Diseases

  2011cites this paper
• Acute Phase Proteins in Prototype Rheumatic Inflammatory Diseases

  2011cites this paper
• Antiphospholipid antibodies and atherosclerosis: insights from rheumatoid arthritis--a five-year follow-up study.

  2011cites this paper
• Lipid profile in Tunisian patients with rheumatoid arthritis

  2011influential citation
• Therapie der Dyslipidämie bei entzündlich-rheumatischen Erkrankungen

  2010cites this paper
• Cardiovascular disease in rheumatoid arthritis: a step forward

  2010cites this paper
• Research update for articles published in EJCI in 2008

  2010cites this paper
• Therapie der Dyslipidämie bei entzündlich-rheumatischen Erkrankungen

  2010cites this paper
• Double role of mannose-binding lectin in relation to carotid intima-media thickness in patients with rheumatoid arthritis.

  2010cites this paper
• [Therapy of dyslipidemia in rheumatic diseases].

  2010cites this paper
• Which Are the Determinants of Dyslipidemia in Rheumatoid Arthritis and Does Socioeconomic Status Matter in This Context?

  2009cites this paper
• Socioeconomic Status Matter in This Context ? Which Are the Determinants of Dyslipidemia in Rheumatoid Arthritis and Does

  2009cites this paper
• Dyslipidaemia in rheumatoid arthritis: the role of inflammation, drugs, lifestyle and genetic factors.

  2009cites this paper
• Polyarthrite rhumatoïde : la lipoprotéine (a) doit faire partie du bilan lipidique

  2009cites this paper